There are 2867 resources available
Q&A and discussiond
Presenter: All Speakers
Session: ESMO Colloquium Supported by Daiichi-Sankyo and AstraZeneca: Targeting HER2 in advanced breast cancer: Successes and perspectives
Resources:
Webcast
The Safer Ukraine Collaborative: Supporting Ukrainian children with cancer affected by war
Presenter: Wojciech Mlynarski
Session: Supporting Ukraine: The European cancer advocacy community responds
Resources:
Slides
Webcast
Q&A
Presenter: Aditya Bardia
Session: F. Hoffman-La Roche LTD - What, why and how: Expert review and opinions on the potential of oral SERDs for our patients with HR+ BC
Resources:
Webcast
Discussion
Presenter: All Speakers
Session: Supporting Ukraine: The European cancer advocacy community responds
Resources:
Slides
Webcast
Close
Presenter: Nick Turner
Session: F. Hoffman-La Roche LTD - What, why and how: Expert review and opinions on the potential of oral SERDs for our patients with HR+ BC
Resources:
Webcast
1488MO - Initial results of phase II/III trial of AL102 for treatment of desmoid tumors (DT)
Presenter: Robin Jones
Session: Mini Oral session: Sarcoma
Resources:
Abstract
Slides
Webcast
623MO - Machine learning-based prediction of germinal center, MYC/BCL2 double protein expressor status, and MYC rearrangement from whole slide images in DLBCL patients
Presenter: Charlotte Syrykh
Session: Mini Oral session: Haematological malignancies
Resources:
Abstract
Slides
Webcast
650O - A phase II study of nivolumab for high-risk oral leukoplakia
Presenter: Glenn Hanna
Session: Proffered Paper session: Head & neck cancer
Resources:
Abstract
Slides
Webcast
1529MO - The genomic landscape of small cell lung cancer in never smoking patients
Presenter: Michael Oh
Session: Mini Oral session: Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
LBA68 - Bempegaldesleukin (BEMPEG) plus nivolumab (NIVO) compared to the investigator’s choice of sunitinib or cabozantinib in previously untreated advanced renal cell carcinoma (RCC): Results from a phase III randomized study (PIVOT-09)
Presenter: Nizar Tannir
Session: Proffered Paper session 2: GU tumours, non-prostate
Resources:
Abstract
Slides
Webcast